Predictions
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.18
04.09.22
04.09.22
-
04.09.23
04.09.23
-9.84%
01.10.22
01.10.22
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.39
03.08.22
03.08.22
€2.80
03.08.23
03.08.23
-14.19%
20.09.22
20.09.22
Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Burcon Nutrascience Corp.
Start price
Target price
Perf. (%)
€1.53
19.09.21
19.09.21
-
19.09.22
19.09.22
-75.74%
20.09.22
20.09.22
Probably not worthwhile Investment
Acasti Pharma Inc.
Start price
Target price
Perf. (%)
€11.77
12.09.21
12.09.21
€15.00
12.09.22
12.09.22
-60.64%
13.09.22
13.09.22
Could be worthwhile Investment >10% per year
Bausch Health Companies Inc.
Start price
Target price
Perf. (%)
€5.40
23.08.22
23.08.22
-
23.08.23
23.08.23
29.96%
09.09.22
09.09.22
Capable Management
Probably not worthwhile Investment
Revenue decline/stagnation expected
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€4.16
24.07.22
24.07.22
-
24.07.23
24.07.23
-2.64%
04.09.22
04.09.22
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€7.85
24.08.22
24.08.22
-
24.08.23
24.08.23
-10.03%
03.09.22
03.09.22
Could be worthwhile Investment >10% per year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.30
26.08.22
26.08.22
-
26.08.23
26.08.23
-4.98%
03.09.22
03.09.22
Canopy Growth Corp
Start price
Target price
Perf. (%)
€7.59
08.01.22
08.01.22
€9.00
08.01.23
08.01.23
-43.48%
26.08.22
26.08.22
Fennec Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€4.40
29.11.21
29.11.21
-
29.11.22
29.11.22
45.45%
10.08.22
10.08.22
Could be worthwhile Investment >10% per year
Xenon Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€26.40
04.10.21
04.10.21
-
04.10.22
04.10.22
45.45%
10.08.22
10.08.22
Could be worthwhile Investment >10% per year
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€10.81
04.07.22
04.07.22
-
04.07.23
04.07.23
-24.63%
06.08.22
06.08.22
Could be worthwhile Investment >10% per year
Bausch Health Companies Inc.
Start price
Target price
Perf. (%)
€8.45
11.07.22
11.07.22
-
11.07.23
11.07.23
-39.77%
04.08.22
04.08.22
Capable Management
Probably not worthwhile Investment
Revenue decline/stagnation expected
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.37
28.04.22
28.04.22
€2.00
28.04.23
28.04.23
0.74%
03.08.22
03.08.22
Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Canopy Growth Corp
Start price
Target price
Perf. (%)
€3.50
11.06.22
11.06.22
€1.90
11.06.23
11.06.23
-16.96%
03.08.22
03.08.22
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€4.09
10.07.22
10.07.22
-
10.07.23
10.07.23
1.76%
23.07.22
23.07.22
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€8.93
09.07.22
09.07.22
€4.00
09.07.23
09.07.23
-40.65%
23.07.22
23.07.22
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€5.41
05.12.21
05.12.21
€3.00
05.12.22
05.12.22
-0.78%
21.07.22
21.07.22
ROE lower than 10% per year
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Canopy Growth Corp
Start price
Target price
Perf. (%)
€3.59
27.06.22
27.06.22
-
27.06.23
27.06.23
-27.90%
09.07.22
09.07.22
Risky Investment
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€4.27
27.06.22
27.06.22
-
27.06.23
27.06.23
-4.35%
09.07.22
09.07.22
Canopy Growth Corp
Start price
Target price
Perf. (%)
€3.50
12.06.22
12.06.22
-
12.06.23
12.06.23
-26.05%
09.07.22
09.07.22
Could be very worthwhile Investment >20% year
Emerald Health Therapeutics Inc
Start price
Target price
Perf. (%)
€0.13
08.07.21
08.07.21
-
08.07.22
08.07.22
-77.81%
08.07.22
08.07.22